Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrigea is an Italian nutraceutical and biotechnology company specializing in the research and development of natural health products derived from Aphanizomenon flos-aquae (Klamath algae). The company is best known for its 'KlamExtra' product line, which utilizes proprietary extraction technologies like Klamin and Aphamax to concentrate specific bioactive molecules such as phenylethylamine and phycocyanins. Nutrigea focuses on therapeutic areas including neurology, immunology, and metabolic health, providing evidence-based natural supplements supported by clinical research. Their business model encompasses the entire value chain from raw material sourcing in Upper Klamath Lake to the formulation and commercialization of finished health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KlamExtra.